Shana De Vos, Simone Janssen, Sophie Favril, Hilde De Cock, Matthijs Vynck, Jonas Steenbrugge, Ward De Spiegelaere, Hilde de Rooster
{"title":"The Poly (ADP-Ribose) Polymerase-1 Enzyme Is Overexpressed in Various Solid Canine Tumours: An Immunohistochemical Study.","authors":"Shana De Vos, Simone Janssen, Sophie Favril, Hilde De Cock, Matthijs Vynck, Jonas Steenbrugge, Ward De Spiegelaere, Hilde de Rooster","doi":"10.1111/vco.13053","DOIUrl":null,"url":null,"abstract":"<p><p>The enzyme poly (ADP-ribose) polymerase-1 (PARP-1) is crucial for cellular regulation and DNA repair. Its immunohistochemical overexpression is known in various human neoplasms, but it was not yet a topic of veterinary research. Formalin-fixed paraffin-embedded canine samples of 15 controls and 34 tumours were immunohistochemically tested for PARP-1 expression. Controls included five skin samples with mast cells, five oral mucosa samples and five thyroid glands. Tumours included 18 mast cell tumours (MCTs), 10 oral squamous cell carcinomas (SCCs) and six follicular thyroid carcinomas. A board-certified veterinary pathologist defined the optimal region for the blind PARP-1 evaluation, assessed by two independent veterinary PhD students. Positive nuclei were evaluated by the immunoreactivity score (IRS) and quick score (QS) and, for both scores, the averages of the two observers were used for statistical analysis. In all MCTs, 6/10 SCCs and all thyroid carcinomas as well as four thyroid controls a nuclear expression was observed. A cytoplasmic granular staining was visible in all dermal mast cells and in 11/18 MCTs due to non-specific antibody uptake. No PARP-1 was expressed in 11/15 controls.Compared to the controls, thyroid carcinomas significantly overexpressed PARP-1 when calculated by IRS and QS (p = 0.003 and p = 0.005, respectively). The latter also applied to the MCTs (p = 0.001). A significantly higher PARP-1 IRS and QS were observed in thyroid carcinomas (p = 0.003, p = 0.005) and MCTs (p = 0.003, p = 0.012) compared to oral SCCs. The immunohistochemical PARP-1 overexpression in these tumours invites further research to assess its potential as a therapeutic target.</p>","PeriodicalId":23693,"journal":{"name":"Veterinary and comparative oncology","volume":" ","pages":"267-277"},"PeriodicalIF":2.3000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary and comparative oncology","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1111/vco.13053","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
The enzyme poly (ADP-ribose) polymerase-1 (PARP-1) is crucial for cellular regulation and DNA repair. Its immunohistochemical overexpression is known in various human neoplasms, but it was not yet a topic of veterinary research. Formalin-fixed paraffin-embedded canine samples of 15 controls and 34 tumours were immunohistochemically tested for PARP-1 expression. Controls included five skin samples with mast cells, five oral mucosa samples and five thyroid glands. Tumours included 18 mast cell tumours (MCTs), 10 oral squamous cell carcinomas (SCCs) and six follicular thyroid carcinomas. A board-certified veterinary pathologist defined the optimal region for the blind PARP-1 evaluation, assessed by two independent veterinary PhD students. Positive nuclei were evaluated by the immunoreactivity score (IRS) and quick score (QS) and, for both scores, the averages of the two observers were used for statistical analysis. In all MCTs, 6/10 SCCs and all thyroid carcinomas as well as four thyroid controls a nuclear expression was observed. A cytoplasmic granular staining was visible in all dermal mast cells and in 11/18 MCTs due to non-specific antibody uptake. No PARP-1 was expressed in 11/15 controls.Compared to the controls, thyroid carcinomas significantly overexpressed PARP-1 when calculated by IRS and QS (p = 0.003 and p = 0.005, respectively). The latter also applied to the MCTs (p = 0.001). A significantly higher PARP-1 IRS and QS were observed in thyroid carcinomas (p = 0.003, p = 0.005) and MCTs (p = 0.003, p = 0.012) compared to oral SCCs. The immunohistochemical PARP-1 overexpression in these tumours invites further research to assess its potential as a therapeutic target.
期刊介绍:
Veterinary and Comparative Oncology (VCO) is an international, peer-reviewed journal integrating clinical and scientific information from a variety of related disciplines and from worldwide sources for all veterinary oncologists and cancer researchers concerned with aetiology, diagnosis and clinical course of cancer in domestic animals and its prevention. With the ultimate aim of diminishing suffering from cancer, the journal supports the transfer of knowledge in all aspects of veterinary oncology, from the application of new laboratory technology to cancer prevention, early detection, diagnosis and therapy. In addition to original articles, the journal publishes solicited editorials, review articles, commentary, correspondence and abstracts from the published literature. Accordingly, studies describing laboratory work performed exclusively in purpose-bred domestic animals (e.g. dogs, cats, horses) will not be considered.